PRAME and triple-negative breast carcinoma: Furthermore, the upregulation of PRAME features cell stemness, invasion, and metastasis in triple-negative breast cancer by promoting the epithelial-to-mesenchymal transition (EMT) through the activation of ZEB1 and downregulation of BMP7 and TSPAN13 genes) [15].